Pharma Reviews: Indian pharma eyes pride of place, may face regulatory hurdles

The USD 32-billion generic-driven Indian pharma industry is eyeing a sea of opportunities as global demand for safe and quality drugs rises, ...
Read more: Indian pharma eyes pride of place, may face regulatory hurdles